Is 1mg of Ozempic Enough for Weight Loss?

Last reviewed: July 3, 2026

Last updated: July 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Understanding Semaglutide Dosing for Weight Loss

Semaglutide works by slowing stomach emptying and signaling fullness to your brain through GLP-1 receptors. The standard dosing protocol starts patients at 0.25mg weekly, escalating by 0.25mg every four weeks until reaching a target maintenance dose, which may range from 1mg to 2.4mg depending on individual tolerance and clinical response. A 1mg weekly injection falls in the lower-to-mid range of typical therapeutic dosing, making it both a common maintenance dose and a stepping stone toward higher amounts.

Real-world effectiveness at 1mg varies considerably among patients. Some individuals experience substantial appetite reduction and consistent weekly weight loss at this dose, while others plateau or see minimal initial changes. This variation stems from differences in GLP-1 receptor density, metabolic rate, insulin sensitivity, and how quickly your body processes the medication—all traits influenced by both genetics and lifestyle factors.

Clinical Evidence: What Studies Show About 1mg Dosing

Large randomized controlled trials of semaglutide demonstrate a dose-response relationship, meaning higher doses generally produce greater weight loss. In the STEP trials (Semaglutide Treatment Effect in People with obesity), participants on 2.4mg achieved average weight loss of approximately 15% of body weight over 68 weeks, while lower-dose groups saw proportionally less dramatic reductions. However, 1mg doses still produced meaningful weight loss in many participants, typically ranging from 5% to 10% of baseline body weight when combined with lifestyle modification.

Individual genetics play a measurable role in semaglutide response. Research has identified specific genetic variants in the GLP1R gene and related metabolic pathways that correlate with medication effectiveness. Some patients with favorable genetic profiles experience robust weight loss at 1mg, while others with less optimal genetic markers may need dose escalation to achieve comparable results—a distinction that genetic testing can help clarify before committing to long-term treatment.

How to Tell If 1mg Is Working for Your Weight Loss

Meaningful weight loss typically becomes visible within 4 to 8 weeks of consistent semaglutide use, though some patients notice appetite changes within days. Track not just the scale, but also hunger levels, food cravings, portion sizes, and energy during daily activities—these subjective markers often appear before significant weight drops. If you're losing 1% to 2% of body weight per week and feeling reduced appetite, your 1mg dose is likely effective. If you've been on 1mg for 12 weeks with minimal appetite suppression or weight loss plateau, dose escalation or clinical reassessment may be necessary.

Environmental and behavioral factors can mask or amplify 1mg effectiveness. A patient eating in a caloric deficit with regular exercise may see strong results at 1mg, while another patient at the same dose without dietary or activity changes may experience disappointment. PlexusDx recommends tracking consumption patterns alongside medication response to distinguish between a dose that isn't working and a dose that needs lifestyle support to reach its full potential.

When and Why Your Semaglutide Dose May Need to Increase

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

PlexusDx Semaglutide Injection pricing remains flat at $189/mo (or $149/mo on the 6-month plan) regardless of dose strength—your dose may need to go up, but your price won't. This transparent pricing model removes financial barriers to dose optimization. If your prescriber determines that 1.5mg, 2mg, or 2.4mg would better match your clinical response and genetic profile, you'll maintain the same monthly commitment, making treatment adjustments accessible and evidence-driven rather than cost-driven.

Genetic Testing and Personalized Semaglutide Response

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) and FTO — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Approximately 49 peptide-pathway insights inform the comprehensive genetic profile, allowing PlexusDx providers to align semaglutide dosing with your inherited metabolic strengths and sensitivities. A patient with favorable GLP-1 receptor variants may see impressive results at 1mg and remain at that dose long-term, reducing overall medication burden and supporting cost-effectiveness. Conversely, a patient with genetic markers suggesting lower GLP-1 receptor sensitivity can understand early that dose escalation will likely be necessary, enabling proactive planning rather than frustrating trial-and-error.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Will 1mg of semaglutide make me lose weight if I don't change my diet?

Semaglutide reduces hunger and portion control, which can lead to caloric deficit and weight loss even without deliberate dietary changes. However, results are typically more modest without conscious eating modifications. Combining 1mg with intentional nutrition and activity choices amplifies weight loss and helps determine whether your dose is truly optimized or if escalation would benefit your goals.

How much weight can I expect to lose on 1mg semaglutide per month?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

How much does semaglutide cost at PlexusDx, and does price change if I need a higher dose?

PlexusDx Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) and remains flat across all dose levels—from 1mg to 2.4mg and beyond. Your dose may need to go up, but your price won't. PlexusDx serves all 50 states with no insurance required, and the medication is HSA/FSA eligible.

Is compounded semaglutide as safe and effective as brand-name Ozempic?

PlexusDx compounded semaglutide comes from licensed 503A compounding pharmacies and contains the same active pharmaceutical ingredient as Ozempic, manufactured under FDA-regulated quality standards. Compounded versions offer cost savings and flexible dosing; they are not FDA-approved as branded products but meet rigorous pharmaceutical standards. Always use medications prescribed by a licensed clinician.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

Yes. The PlexusDx Precision Peptide Genetic Test ($298) analyzes GLP-1 receptor variants and 48 other peptide-pathway genes to estimate your individual semaglutide responsiveness. Results help your provider anticipate whether 1mg will produce optimal appetite suppression or whether planned dose escalation is likely necessary, enabling personalized, evidence-based dosing strategies.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.